Gene: CWC15
Official Full Name: CWC15 spliceosome associated protein homologprovided by HGNC
Gene Summary: Predicted to enable RNA binding activity. Involved in mRNA splicing, via spliceosome. Located in mitochondrion and nuclear speck. Part of Prp19 complex and U2-type catalytic step 2 spliceosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22467 | CWC15 Knockout cell line (HeLa) | Human | CWC15 | 1:3~1:6 | Negative | Online Inquiry |
KO22468 | CWC15 Knockout cell line (HCT 116) | Human | CWC15 | 1:2~1:4 | Negative | Online Inquiry |
KO22469 | CWC15 Knockout cell line (HEK293) | Human | CWC15 | 1:3~1:6 | Negative | Online Inquiry |
KO22470 | CWC15 Knockout cell line (A549) | Human | CWC15 | 1:3~1:4 | Negative | Online Inquiry |
CWC15 Gene Knockout Cell Lines are genetically engineered cell lines designed to knock out the specific gene CWC15, which encodes a protein involved in pre-mRNA splicing and, consequently, various cellular processes such as gene expression regulation and RNA metabolism. By utilizing CRISPR/Cas9 technology for precise genomic editing, these cell lines enable researchers to investigate the functional consequences of CWC15 loss, thereby providing insights into the biological pathways and molecular interactions that the gene influences.
The primary function of CWC15 Gene Knockout Cell Lines lies in their ability to facilitate studies on gene function, spliceosomal dynamics, and the broader implications of splicing abnormalities in disease states. They provide a valuable tool for dissecting mechanisms underlying cancer, neurodegenerative disorders, and other conditions linked to dysregulation of alternative splicing. Researchers can leverage these knockout models to assess phenotypic changes, identify compensatory pathways, and validate therapeutic targets.
In the realm of scientific research and clinical applications, these cell lines stand out for their rigorously validated genomic alterations and reproducibility, which are essential for ensuring reliable experimental outcomes. Unlike alternative models, CWC15 knockout lines are optimized for robustness and ease of use, facilitating the rapid generation of data for high-throughput screening assays or targeted studies.
For researchers and clinicians focused on understanding gene function and exploring innovative treatment strategies, the availability of CWC15 Gene Knockout Cell Lines simplifies experimental design while enhancing the translational potential of their findings. Their targeted approach offers a distinct advantage in dissecting complex biological questions with a high degree of specificity and control.
At the forefront of genetic research, our company specializes in providing high-quality biological resources, and our CWC15 Gene Knockout Cell Lines exemplify our commitment to advancing scientific discovery through precision tools.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.